Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Nov;30(2):259–261.

The high prevalence of HLA-B5 in Behçet's disease.

H Yazici, G Akokan, B Yalçin, A Müftüoğlu
PMCID: PMC1541115  PMID: 606446

Abstract

Sixteen of the nineteen (84%) patients with Behçet's disease in Turkey had HLA-B5; the prevalence of HLA-B5 among 150 controls was 27%.

Full text

PDF
259

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Curran R. E. Behçet's disease. Ann Intern Med. 1972 Feb;76(2):332–333. doi: 10.7326/0003-4819-76-2-332. [DOI] [PubMed] [Google Scholar]
  2. Jung R. T., Chalmers T. M., Joysey V. C. HLA in Behçet's disease. Lancet. 1976 Mar 27;1(7961):694–694. doi: 10.1016/s0140-6736(76)92809-9. [DOI] [PubMed] [Google Scholar]
  3. Mason R. M., Barnes C. G. Behçet's syndrome with arthritis. Ann Rheum Dis. 1969 Mar;28(2):95–103. doi: 10.1136/ard.28.2.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. O'Duffy J. D., Carney J. A., Deodhar S. Behçet's disease. Report of 10 cases, 3 with new manifestations. Ann Intern Med. 1971 Oct;75(4):561–570. doi: 10.7326/0003-4819-75-4-561. [DOI] [PubMed] [Google Scholar]
  5. Ono S., Nakayama E., Sugiura S., Itakura K., Aoki K. Specific histocompatibility antigens associated with Behçet's disease. Am J Ophthalmol. 1975 Oct;80(4):636–641. doi: 10.1016/0002-9394(75)90394-3. [DOI] [PubMed] [Google Scholar]
  6. TERASAKI P. I., MCCLELLAND J. D. MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964 Dec 5;204:998–1000. doi: 10.1038/204998b0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES